Fermenta Biotech

 Fermenta Biotech

About Fermenta Biotech

About Fermenta Biotech
Founded in
1951 (73 yrs old) Ownership
Public
India Employee count
501-1k Global Employee count
501-1k Headquarters
Thane, Maharashtra, India
Office Locations
Thane
| Mandi | Naidupet |
1+
CEO Suggest Founders Suggest Type of Company
Corporate
Nature of Business
B2B
Company Email ID Suggest Company Contact no. Suggest Social Media Presence Suggest Website
fermentabiotech.com
Fermenta Biotech manufactures Cholecalciferol (Vitamin D3), Lipase Enzymes & Environmental solutions for Waste Water Management. Fermenta Biotech Limited, founded in 1951, is the only manufacturer of Vitamin D in India and a leading global player. Headquartered in Thane, FBL’s manufacturing facilities in Kullu and Dahej are certificated by global accreditations and its world class R&D centre is also located at Thane.  Fermenta’s legacy in Vitamin D spans across 55 years and we cater to more than 350 customers across 60 countries. Our global presence is further enhanced by our international subsidiaries in Germany and the US. Our offerings include Vitamin D variants for pharmaceuticals, DNS, food, veterinary, feed as well as rodenticides. Apart from Vitamin D3, FBL also possesses expertise in integrated biotechnology solutions such as enzymes for antibiotic synthesis and other niche APIs.  Fermenta produces enzymes for manufacturing ingredients with applications in the pharmaceutical, food & fragrances, oleo, biodiesel, leather and fine chemical industries. It offers products and services related to waste water management and treatment solutions. The Company offers fish oil-derived cholesterol for aquaculture nutrition and recently added natural astaxanthin as well as Vitamin AD2 premix to its nutritional ingredients basket. Building on our expertise in Vitamin D, Fermenta has now entered into the nutrition portfolio with new products for human and animal nutrition. We are proud to play a role in ensuring the health of communities across the globe.  Over the last decade, Fermenta has expanded from a solely domestic focused business to a global company, with more than 60% of revenues now arising from exports. It has established two wholly-owned international subsidiaries – Fermenta Biotech GmbH in Germany and Fermenta Biotech USA LLC, in USA. Fermenta Biotech USA LLC acquired a majority stake in US-based vitamins player which was renamed as Fermenta USA LLC. Fermenta – Great Place to Work certified: After undergoing a rigorous evaluation of the quality of its employee experience and people practices, Fermenta emerged among just eightorganisations to be recognised as one of India’s Best Workplaces in Biotechnology & Pharmaceuticals for 2021. The Company received a Great Place to Work certification, April 2022 to April 2023, for the fourth year in a row, and was recognised for its commitment to being agreat workplace. Mr. Prashant Nagre, Managing Director of Fermenta, was recognised among India’s Best Leaders in Times of Crisis 2021.What drives Fermenta: Our passion for eliminating hidden hungerOur commitment towards our global clienteleOur demand-driven innovation focusOur dedicated knowledge bandwidth of subject matter expertsOur continuous pursuit of excellence in delivery systemsOur research and manufacturing infrastructureOur endeavour to create shared value for all stakeholdersOur aspiration for healthier lives and stronger communities Mission: To produce high quality niche products, used in every line of pharmaceutical, food and fine chemical manufacture, through innovative and concentrated research efforts, thus becoming the most preferred eco-friendly solutions provider in bio-catalysis and pharmaceuticals.
Vision: To create a system and nurture it to reach a state of functioning, enabling it to acquire a state of timeless stability and growth.

Primary Industry

i

Primary industry refers to the industry from which a company drives
its maximum revenue.

Pharma

(Healthcare)
Other Industry

i

Other industries refer to additional industries in which a company
operates other than its primary industry.

Financial Services

Report error